Vascular access devices are becoming increasingly popular in the United States. However, during the COVID-19 pandemic, the quantity of units purchased decreased, and this trend continued into 2022. Nevertheless, the market is anticipated to experience growth in 2023 and beyond, driven by various factors, including government policies that promote safer practices and products. Within our
Vascular Access Devices: Who are the Top Competitors and What Products do They Offer?
WHAT ARE VASCULAR ACCESS DEVICES? A vascular access device is a medical device that’s purpose is to access a patient’s veins and arteries. Additionally, vascular access accessories are used to improve safety and overall performance. Catheters are one of the main vascular access devices used and their indications for use include the administration of drugs,
Your 2 Minute Guide to the Global Vascular Access Device Market
Overall, the global vascular access device market was valued at $4.2 billion, with around 1 billion vascular access devices placed each year. The market size is expected to increase over the forecast period and reach $4.8 billion in 2026. HOW ARE VASCULAR ACCESS DEVICES USED? iData’s global market report for vascular access devices includes both
6 Global Trends You Should Be Aware of in the Central Venous Catheter Market
iData’s report on the global central venous catheter (CVC) market includes both acute and chronic CVC’s. In the past, the central venous catheter market suffered extreme consequences after the Joint Commission guidelines recommended that catheters should only be placed in the femoral vein if no other sites are available. This recommendation was due to the
What Will Canada’s Vascular Access Market Look Like in the Future?
Canada’s vascular access market includes medical devices with the ability to access a patient’s veins and arteries as well as accessories to improve safety and performance. By 2026, Canada’s vascular access market expects to reach $352.5 million at a CAGR of 2%. Overall, there are many vascular access devices, and iData’s analysis includes a wide
Challenges and Opportunities in the U.S. Market for Central Venous Catheters
What are Central Venous Catheters? In emergency and non-emergency situations, central venous catheters, in short, CVCs, gain immediate high-flow vascular access. Because of the higher potential flow rates, veins with larger diameters such as the jugular, subclavian, and femoral veins are the best for CVCs as they accommodate more lumens. In situations where patients require
Top TAVR Companies in Europe
Based on the latest market analysis by iData Research, the European Transcatheter Aortic Valve Replacement (also known as TAVR/TAVI) market was valued at €836.2 million in 2020, which is a 29% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace the diseased aortic valve in patients with severe aortic stenosis.
Top 3 Syringe and Needle Companies in the United States
As we progress through the global pandemic and drive closer to having a vaccine available, companies are now preparing supplies such as needles and syringes. We have compiled the top three companies to watch as distributors for needles and syringes in the United States. Becton Dickinson Cardinal Health Novo Nordisk Becton Dickinson Becton Dickinson produces
Teleflex Announces Expanded Indications For Intraosseous Vascular Access System
Teleflex has announced its receival of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for the use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device is used to provide procedural guidance within the establishment of intraosseous vascular access, especially when intravenous access is difficult to obtain in
Over 2.7 million PICC line insertion procedures are performed each year in the United States
According to the latest vascular access device market analysis by iData Research, there are over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year in the United States. The overall US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. PICC insertions